565 related articles for article (PubMed ID: 9816062)
1. Epidermal growth factor receptor and transforming growth factor alpha expression in papillary and nonpapillary renal cell carcinoma: correlation with metastatic behavior and prognosis.
Uhlman DL; Nguyen P; Manivel JC; Zhang G; Hagen K; Fraley E; Aeppli D; Niehans GA
Clin Cancer Res; 1995 Aug; 1(8):913-20. PubMed ID: 9816062
[TBL] [Abstract][Full Text] [Related]
2. The expression of epidermal growth factor receptor and transforming growth factor alpha in renal cell carcinoma.
Lager DJ; Slagel DD; Palechek PL
Mod Pathol; 1994 Jun; 7(5):544-8. PubMed ID: 7937720
[TBL] [Abstract][Full Text] [Related]
3. Clinical relevance of transforming growth factor alpha, epidermal growth factor receptor, p53, and Ki67 in colorectal liver metastases and corresponding primary tumors.
De Jong KP; Stellema R; Karrenbeld A; Koudstaal J; Gouw AS; Sluiter WJ; Peeters PM; Slooff MJ; De Vries EG
Hepatology; 1998 Oct; 28(4):971-9. PubMed ID: 9755233
[TBL] [Abstract][Full Text] [Related]
4. Significance of tyrosine kinase activity on malign transformation of ovarian tumors: a comparison between EGF-R and TGF-alpha.
Zeren T; Inan S; Seda Vatansever H; Ekerbicer N; Sayhan S
Acta Histochem; 2008; 110(3):256-63. PubMed ID: 18054376
[TBL] [Abstract][Full Text] [Related]
5. Expression of epidermal growth factor, transforming growth factor-alpha and epidermal growth factor receptor in thyroid tumors.
Gorgoulis V; Aninos D; Priftis C; Evagelopoulou C; Karameris A; Kanavaros P; Spandidos DA
In Vivo; 1992; 6(3):291-6. PubMed ID: 1391697
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of the epidermal growth factor receptor and its ligand transforming growth factor alpha is frequent in resectable non-small cell lung cancer but does not predict tumor progression.
Rusch V; Klimstra D; Venkatraman E; Pisters PW; Langenfeld J; Dmitrovsky E
Clin Cancer Res; 1997 Apr; 3(4):515-22. PubMed ID: 9815714
[TBL] [Abstract][Full Text] [Related]
7. Differential expression of the epidermal growth factor receptor and its ligands in primary non-small cell lung cancers and adjacent benign lung.
Rusch V; Baselga J; Cordon-Cardo C; Orazem J; Zaman M; Hoda S; McIntosh J; Kurie J; Dmitrovsky E
Cancer Res; 1993 May; 53(10 Suppl):2379-85. PubMed ID: 7683573
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical detection of epidermal growth factor receptor lacks prognostic significance for breast carcinoma.
Göhring UJ; Ahr A; Scharl A; Weisner V; Neuhaus W; Crombach G; Holt JA
J Soc Gynecol Investig; 1995; 2(4):653-9. PubMed ID: 9420872
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical analysis with multiple antibodies in search of prognostic markers for clear cell renal cell carcinoma.
Phuoc NB; Ehara H; Gotoh T; Nakano M; Yokoi S; Deguchi T; Hirose Y
Urology; 2007 May; 69(5):843-8. PubMed ID: 17482919
[TBL] [Abstract][Full Text] [Related]
10. Significance of heat shock protein-27 expression in patients with renal cell carcinoma.
Erkizan O; Kirkali G; Yörükoğlu K; Kirkali Z
Urology; 2004 Sep; 64(3):474-8. PubMed ID: 15351573
[TBL] [Abstract][Full Text] [Related]
11. Pax-2 expression in adult renal tumors.
Daniel L; Lechevallier E; Giorgi R; Sichez H; Zattara-Cannoni H; Figarella-Branger D; Coulange C
Hum Pathol; 2001 Mar; 32(3):282-7. PubMed ID: 11274636
[TBL] [Abstract][Full Text] [Related]
12. Morphologic typing of papillary renal cell carcinoma: comparison of growth kinetics and patient survival in 66 cases.
Delahunt B; Eble JN; McCredie MR; Bethwaite PB; Stewart JH; Bilous AM
Hum Pathol; 2001 Jun; 32(6):590-5. PubMed ID: 11431713
[TBL] [Abstract][Full Text] [Related]
13. Transforming growth factor-alpha, epidermal growth factor receptor, and MiB-1 expression in Barrett's-associated neoplasia: correlation with prognosis.
Yacoub L; Goldman H; Odze RD
Mod Pathol; 1997 Feb; 10(2):105-12. PubMed ID: 9127315
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of EGF receptor and tumor cell proliferation in bladder cancer: therapeutic implications.
Popov Z; Gil-Diez-De-Medina S; Ravery V; Hoznek A; Bastuji-Garin S; Lefrere-Belda MA; Abbou CC; Chopin DK
Urol Oncol; 2004; 22(2):93-101. PubMed ID: 15082004
[TBL] [Abstract][Full Text] [Related]
15. Heparin-binding epidermal growth factor-like growth factor isoforms and epidermal growth factor receptor/ErbB1 expression in bladder cancer and their relation to clinical outcome.
Kramer C; Klasmeyer K; Bojar H; Schulz WA; Ackermann R; Grimm MO
Cancer; 2007 May; 109(10):2016-24. PubMed ID: 17394193
[TBL] [Abstract][Full Text] [Related]
16. Expression of neu protein, epidermal growth factor receptor, and transforming growth factor alpha in breast cancer. Correlation with clinicopathologic parameters.
Lundy J; Schuss A; Stanick D; McCormack ES; Kramer S; Sorvillo JM
Am J Pathol; 1991 Jun; 138(6):1527-34. PubMed ID: 1711294
[TBL] [Abstract][Full Text] [Related]
17. Expression of EGF, TGF-alpha and EGFR in squamous cell lung carcinomas.
Gorgoulis V; Aninos D; Mikou P; Kanavaros P; Karameris A; Joardanoglou J; Rasidakis A; Veslemes M; Ozanne B; Spandidos DA
Anticancer Res; 1992; 12(4):1183-7. PubMed ID: 1503407
[TBL] [Abstract][Full Text] [Related]
18. Coexpression of epidermal growth factor receptor and TGF-alpha and survival in upper aerodigestive tract cancer.
Issing WJ; Liebich C; Wustrow TP; Ullrich A
Anticancer Res; 1996; 16(1):283-8. PubMed ID: 8615622
[TBL] [Abstract][Full Text] [Related]
19. Differential expression of growth factors in squamous cell carcinoma and precancerous lesions of the lung.
Piyathilake CJ; Frost AR; Manne U; Weiss H; Bell WC; Heimburger DC; Grizzle WE
Clin Cancer Res; 2002 Mar; 8(3):734-44. PubMed ID: 11895903
[TBL] [Abstract][Full Text] [Related]
20. Clinicopathologic and molecular correlations of necrosis in the primary tumor of patients with renal cell carcinoma.
Lam JS; Shvarts O; Said JW; Pantuck AJ; Seligson DB; Aldridge ME; Bui MH; Liu X; Horvath S; Figlin RA; Belldegrun AS
Cancer; 2005 Jun; 103(12):2517-25. PubMed ID: 15880379
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]